1 Dominique L.Drug-induced liver diseases [J].J Hepatology,2000,32(S):77-88
2 王纪东,马建平,王桂林,等.老年人药源性肝病33例[J].中国老年学杂志,2004,24(8):764-765
3 上海医科大学《实用内科学》编辑委员会.实用内科学(第10版)[M].北京:人民卫生出版社,1997:1692-1695
4 桀本俊一,思地森一,周防武昭,他.药物性肝障害の诊断さ治疗[J].肝胆肝萃.2000,40(6):887-897
5 丰田隆谦,上野义之.Rifampicin诱导体の临床治疗效果さ副作用[J].日本临床.2000,58(2) :376 382
6 Kaplovitz N.Drug-induced liver disorders:implication for drug develop-ment and regulation[J].Drug Saf,2001,24(2):483-490
7 Bissell DM, Gores GJ,Laskin DL,et al.Drug-induced liver injury:mechanisms and test Bystermst [J].Hepatology,2001,33(9):1009-1013
8 大部诚.药物性肝障害病理[J].肝胆肝萃,2000,40(6):871-880
9 高殿举,曲桂香,张丽.抗结核药物对肝脏损害69例临床观察分析[J].吉林医学院学报,1997,17(2):43-45
10 俞计明,吴立萍,韩卫华.抗结核药物所致肝损害78例防治分析[J].实用医学杂志,2003,19(6) :659-661
11 Jasmer RM. Daley CL.Rifampicin and pyrazinamide for treatment of la-tent tuberculosis infection:is it safe? [J].Am J Respir Crit Care Med,2003,167(6):809-810
12 Sodhi CP,Rana S,Mehta S,et al.Study of oxidative-stress in ri-fampicin-induced hepatic injury in growing rats with and without pro-tein-energy malnutrition[J].Hum Exp Toxicol,1997,16(6):315-321
13 Sodhi CP, Rana SF,Attn S,et al.Oxidative-hepatic injury of isoniazid-rifampicin in young rats subjected to protein and energy malnutrition[J]. Drug Chem Toxicol, 1998,21(3):305-317
14 厉有名.药物性肝损害的临床类型及诊断策略[J].中华肝脏病杂志,2004,12(7):445-446
15 姚祯,王朝栋.老年药物性肝损害[J].实用老年医学,1995,9(3):102-103
16 姚光弼.老年性药物肝损害[J].老年医学与保健,2002,8(1):3
|